Portola Pharmaceuticals, Inc. (PTLA)

35.99
NASDAQ
Prev Close 35.76
Day Low/High 35.02 / 36.69
52 Wk Low/High 14.81 / 45.60
Exchange NASDAQ
Shares Outstanding 68.02B
Market Cap 2.43B
Div & Yield N.A. (N.A)

Latest News

Interesting PTLA Put And Call Options For September 20th

Interesting PTLA Put And Call Options For September 20th

Investors in Portola Pharmaceuticals, Inc. saw new options become available this week, for the September 20th expiration.

Interesting PTLA Put And Call Options For February 15th

Interesting PTLA Put And Call Options For February 15th

Investors in Portola Pharmaceuticals, Inc. saw new options become available this week, for the February 15th expiration.

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

First Week Of June 2019 Options Trading For Portola Pharmaceuticals (PTLA)

First Week Of June 2019 Options Trading For Portola Pharmaceuticals (PTLA)

Investors in Portola Pharmaceuticals, Inc. saw new options become available this week, for the June 2019 expiration.

First Week Of November 16th Options Trading For Portola Pharmaceuticals (PTLA)

First Week Of November 16th Options Trading For Portola Pharmaceuticals (PTLA)

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the November 16th expiration.

First Week Of January 2021 Options Trading For Portola Pharmaceuticals (PTLA)

First Week Of January 2021 Options Trading For Portola Pharmaceuticals (PTLA)

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the January 2021 expiration.

Insider Buys of 2 Down Stocks Catch My Eye

Insider Buys of 2 Down Stocks Catch My Eye

Big insider purchases at Portola Pharmaceuticals and Alta Mesa Resources could be revealing.

Interesting PTLA Put And Call Options For October 19th

Interesting PTLA Put And Call Options For October 19th

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the October 19th expiration.

Diamondback Energy, Illinois Tool Works, Xerox: 'Mad Money' Lightning Round

Diamondback Energy, Illinois Tool Works, Xerox: 'Mad Money' Lightning Round

Jim Cramer weighs in on Diamondback Energy, Illinois Tool Works, Xerox, PetMed Express, STMicroelectronics, Booking and more.

Time to Cool Off: Cramer's 'Mad Money' Recap (Friday 5/11/18)

Time to Cool Off: Cramer's 'Mad Money' Recap (Friday 5/11/18)

Upcoming earnings? Optimistic spin on trade? Tech rally? Jim Cramer's got the game plan for next week and he tells investors to keep their cool.

Noteworthy Monday Option Activity: PTLA, W, EHTH

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Portola Pharmaceuticals, Inc. , where a total of 6,062 contracts have traded so far, representing approximately 606,200 underlying shares.

First Week Of December 21st Options Trading For Portola Pharmaceuticals (PTLA)

Investors in Portola Pharmaceuticals, Inc. saw new options begin trading this week, for the December 21st expiration.

Portola Pharmaceuticals Announces Results Of CHMP Oral Explanations For Andexanet Alfa And Betrixaban

Portola Pharmaceuticals Announces Results Of CHMP Oral Explanations For Andexanet Alfa And Betrixaban

Company to Host Conference Call on Tuesday, February 20, 2018, at 5:00 p.m. ET

Portola Pharmaceuticals Stock Sees Short Interest Increase 14.2%

Portola Pharmaceuticals Stock Sees Short Interest Increase 14.2%

The most recent short interest data has been released for the 01/12/2018 settlement date, which shows a 553,785 share increase in total short interest for Portola Pharmaceuticals, Inc. , to 4,455,929, an increase of 14.19% since 12/29/2017.

TheStreet Quant Rating: D- (Sell)